Search

Robert E. Mosser

Examiner (ID: 16617, Phone: (571)272-4451 , Office: P/3714 )

Most Active Art Unit
3715
Art Unit(s)
3714, 3715, 3713, 3712
Total Applications
839
Issued Applications
347
Pending Applications
141
Abandoned Applications
372

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11798518 [patent_doc_number] => 09539235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-10 [patent_title] => 'Methods for Alzheimer\'s disease treatment and cognitive enhancement' [patent_app_type] => utility [patent_app_number] => 13/851161 [patent_app_country] => US [patent_app_date] => 2013-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 9022 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13851161 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/851161
Methods for Alzheimer's disease treatment and cognitive enhancement Mar 26, 2013 Issued
Array ( [id] => 13253273 [patent_doc_number] => 10139320 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-27 [patent_title] => Composition for processing histological, postmortem, cytological samples [patent_app_type] => utility [patent_app_number] => 14/388754 [patent_app_country] => US [patent_app_date] => 2013-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2780 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388754 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/388754
Composition for processing histological, postmortem, cytological samples Mar 24, 2013 Issued
Array ( [id] => 10587606 [patent_doc_number] => 09309208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-12 [patent_title] => 'Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors' [patent_app_type] => utility [patent_app_number] => 13/849339 [patent_app_country] => US [patent_app_date] => 2013-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 19 [patent_no_of_words] => 5913 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13849339 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/849339
Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors Mar 21, 2013 Issued
Array ( [id] => 9192135 [patent_doc_number] => 20130331450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'CLASS II HMG-COA REDUCTASE INHIBITORS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/836743 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12461 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13836743 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/836743
Class II HMG-COA reductase inhibitors and methods of use Mar 14, 2013 Issued
Array ( [id] => 9932150 [patent_doc_number] => 20150080342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'BENZOXABOROLE COMPOUNDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/394427 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13870 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14394427 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/394427
BENZOXABOROLE COMPOUNDS AND USES THEREOF Mar 14, 2013 Abandoned
Array ( [id] => 15510217 [patent_doc_number] => 10561675 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-18 [patent_title] => Cyclic boronic acid ester derivatives and therapeutic uses thereof [patent_app_type] => utility [patent_app_number] => 13/843579 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16553 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13843579 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/843579
Cyclic boronic acid ester derivatives and therapeutic uses thereof Mar 14, 2013 Issued
Array ( [id] => 9771103 [patent_doc_number] => 20140294766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'Anti-Infective Agents and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/838223 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 87736 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13838223 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/838223
Anti-infective agents and uses thereof Mar 14, 2013 Issued
Array ( [id] => 9422425 [patent_doc_number] => 20140107076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'CRYSTALLIZATION METHOD AND BIOAVAILABILITY' [patent_app_type] => utility [patent_app_number] => 13/826691 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 10838 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13826691 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/826691
Crystallization method and bioavailability Mar 13, 2013 Issued
Array ( [id] => 9739288 [patent_doc_number] => 20140275007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'OXAMAZIN ANTIBIOTICS' [patent_app_type] => utility [patent_app_number] => 13/829304 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13684 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13829304 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/829304
OXAMAZIN ANTIBIOTICS Mar 13, 2013 Abandoned
Array ( [id] => 10705344 [patent_doc_number] => 20160051491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'NOVEL USE OF PINOSYLVIN FOR ANGIOGENESIS PROMOTION' [patent_app_type] => utility [patent_app_number] => 14/768110 [patent_app_country] => US [patent_app_date] => 2013-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5706 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14768110 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/768110
NOVEL USE OF PINOSYLVIN FOR ANGIOGENESIS PROMOTION Mar 12, 2013 Abandoned
Array ( [id] => 8927628 [patent_doc_number] => 20130183388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'Novel IDO Inhibitors and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/777383 [patent_app_country] => US [patent_app_date] => 2013-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6893 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13777383 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/777383
Novel IDO Inhibitors and Methods of Use Thereof Feb 25, 2013 Abandoned
Array ( [id] => 10202685 [patent_doc_number] => 20150087674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEVERE PAIN' [patent_app_type] => utility [patent_app_number] => 14/399201 [patent_app_country] => US [patent_app_date] => 2013-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8957 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399201 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/399201
COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEVERE PAIN Feb 22, 2013 Abandoned
Array ( [id] => 9686615 [patent_doc_number] => 20140243381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'FURYL AND THIENYL TRIAZOLE DERIVATIVES AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/774231 [patent_app_country] => US [patent_app_date] => 2013-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5702 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13774231 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/774231
Furyl and thienyl triazole derivatives and therapeutic uses thereof Feb 21, 2013 Issued
Array ( [id] => 9865380 [patent_doc_number] => 20150045400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'RITONAVIR COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/382075 [patent_app_country] => US [patent_app_date] => 2013-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2859 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382075 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/382075
RITONAVIR COMPOSITIONS Feb 17, 2013 Abandoned
Array ( [id] => 10248506 [patent_doc_number] => 20150133503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING TUBERCULOSIS' [patent_app_type] => utility [patent_app_number] => 14/382548 [patent_app_country] => US [patent_app_date] => 2013-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7342 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382548 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/382548
Pharmaceutical composition for preventing or treating tuberculosis Feb 12, 2013 Issued
Array ( [id] => 9331093 [patent_doc_number] => 20140057875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'CRYSTALLIZATION METHOD AND BIOAVAILABILITY' [patent_app_type] => utility [patent_app_number] => 13/766034 [patent_app_country] => US [patent_app_date] => 2013-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 10862 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13766034 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/766034
Crystallization method and bioavailability Feb 12, 2013 Issued
Array ( [id] => 10234369 [patent_doc_number] => 20150119363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-30 [patent_title] => 'METHODS OF TREATING BACTERIAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 14/377163 [patent_app_country] => US [patent_app_date] => 2013-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 47610 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14377163 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/377163
METHODS OF TREATING BACTERIAL INFECTIONS Feb 10, 2013 Abandoned
Array ( [id] => 10844612 [patent_doc_number] => 08871789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-28 [patent_title] => 'Method of preventing or treating viral infection' [patent_app_type] => utility [patent_app_number] => 13/747406 [patent_app_country] => US [patent_app_date] => 2013-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 61 [patent_no_of_words] => 12602 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13747406 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/747406
Method of preventing or treating viral infection Jan 21, 2013 Issued
Array ( [id] => 8830076 [patent_doc_number] => 20130131121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'ANTI-VIRAL AGENT' [patent_app_type] => utility [patent_app_number] => 13/744913 [patent_app_country] => US [patent_app_date] => 2013-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5019 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13744913 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/744913
ANTI-VIRAL AGENT Jan 17, 2013 Abandoned
Array ( [id] => 8951119 [patent_doc_number] => 20130196900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'ENHANCEMENT OF INNATE RESISTANCE TO INFECTION' [patent_app_type] => utility [patent_app_number] => 13/744931 [patent_app_country] => US [patent_app_date] => 2013-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11803 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13744931 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/744931
ENHANCEMENT OF INNATE RESISTANCE TO INFECTION Jan 17, 2013 Abandoned
Menu